FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
FMC Corp Executive VP & Chief HRO Jacqueline Scanlan sold 4,930 shares of common stock on November 3, 2026, at $6.55 per share. After the sale, she reported direct ownership of 58,628 shares. The sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted July 31, 2026.
FMC Corp. officer Jacqueline D. Scanlan reported a proposed sale of 4,930 common shares, with an aggregate market value of $32,291.50 and an approximate sale date of November 3, 2026. Fidelity Brokerage Services LLC is listed as broker. The shares are attributed to restricted-stock vesting: 1,913 shares dated September 27, 2025, and 3,017 shares dated September 27, 2026.
FMC Corporation reported third-quarter revenue of $105.9 million, versus $542.2 million a year earlier, and a net loss attributable to FMC stockholders of $2,066.9 million, compared with $569.3 million. For the first nine months of 2026, revenue was $1,731.6 million versus $2,384.1 million, and stockholder net loss was $2,534.8 million versus $518.1 million. Revenue included approximately $639 million of charges tied to commercial actions; continuing-operations cash used was $231.3 million versus $663.3 million.
In September 2026, Tessenderlo Group bought 30,319,166 FMC shares at $13.30 each, representing approximately 20% of outstanding shares; FMC received $403.2 million and used proceeds to pay down Revolving Credit Facility borrowings and for general corporate purposes. Under a June agreement with Corteva, FMC retains ownership of rimisoxafen and received a $200.0 million initial prepurchase payment for supply.
FMC signed an agreement to sell its India commercial business to Crystal Crop Protection Limited for $252 million, subject to customary adjustments for cash, debt and working capital; closing was expected during 2026. FMC also recorded a $287.5 million non-cash impairment of crop-protection brand intangibles during the nine months.
FMC Corp common stock: Vanguard Portfolio Management reported beneficial ownership of 7,835,867 shares, or 5.03% of the class. It reported sole voting power over 215,165 shares and sole dispositive power over 7,835,867 shares; shared voting and dispositive power were 0 shares.
The reported position includes securities held by Vanguard funds over which Vanguard Portfolio Management exercises dispositive power, and client securities over which Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC exercise dispositive and/or voting power. No other person's interest in the reported securities exceeds 5%. My Trieu-Gatt is identified as Authorized Signatory, Head of Global Fund Administration.
For FMC Corp common stock, Vanguard Capital Management reported beneficial ownership of 6,624,753 shares, or 4.25%, as of September 30, 2026. It reported sole voting power over 985,640 shares and sole dispositive power over 6,624,753 shares, with no shared voting or dispositive power.
The reported amount includes securities held by Vanguard funds, client accounts and listed Vanguard affiliates. My Trieu-Gatt signed as Authorized Signatory, Head of Global Fund Administration.
FMC Corporation reported third-quarter 2026 revenue of $106 million, down $436 million from Q3 2025; previously announced commercial actions had a $639 million negative revenue impact. GAAP net loss was $2.07 billion, versus $569 million, and Adjusted EBITDA was negative $559 million, versus $236 million. FMC attributed the loss to non-cash adjustments for deferred tax assets and intangible assets, along with the commercial actions. The actions reduced Adjusted EBITDA by approximately $672 million. Cash from operations was $7 million, versus negative $184 million, and free cash flow was negative $18 million, an improvement of $214 million.
FMC lowered its fourth-quarter outlook to revenue excluding India of $1.04 billion to $1.14 billion, Adjusted EBITDA of $210 million to $230 million, and adjusted earnings per diluted share of $0.56 to $0.70; midpoint comparisons show flat revenue, 22% lower EBITDA and 48% lower adjusted EPS versus Q4 2025. Full-year 2026 revenue excluding India is expected at $2.75 billion to $2.85 billion; Adjusted EBITDA at negative $124 million to negative $104 million; and free cash flow at negative $350 million to negative $150 million, including approximately $180 million of restructuring spend. The North America pricing and rebate model transition is expected over the next three quarters.
FMC Corporation common stock is the subject of BlackRock, Inc.’s Amendment No. 21 ownership report. BlackRock reports beneficial ownership of 19,212,962 shares, or 12.4% of the class, through certain business units, subsidiaries and affiliates. The reported amount excludes business units whose ownership is disaggregated.
BlackRock reports sole voting power over 18,897,256 shares and sole dispositive power over 19,212,962 shares; shared voting and dispositive power are both zero. Various persons may receive dividends or sale proceeds, but no one person’s interest exceeds 5% of FMC’s outstanding common shares.
FMC Corporation appointed Luc Tack, Tessenderlo Group NV’s nominee, as a director effective October 21, 2026, and appointed him to its Sustainability & Innovation Committee. Under the Investor Agreement, FMC increased its board from 9 to 10 directors.
FMC and Tessenderlo Group completed their previously agreed sale of 30,319,166 shares of FMC common stock at $13.30 per share, for an aggregate purchase price of $403,244,907.80, on September 23, 2026. Tack, Tessenderlo Group’s CEO since December 2013, will receive standard non-employee director compensation. In lieu of an annual restricted stock unit grant, he will receive an equivalent amount of cash, paid at the same time and subject to the same terms as his annual cash retainer; he cannot elect to receive any part of that retainer in restricted stock units.
FMC Corporation entered into Amendment No. 8 to its Fifth Amended and Restated Credit Agreement on October 15, 2026. The amendment adds a covenant requiring FMC to use net cash proceeds received from its previously announced sale of its commercial business in India to repay debt under the Credit Agreement or for general corporate or working capital purposes. It also conditionally releases certain guarantors from their guarantees and certain assets from the security interest securing the Credit Agreement, to permit FMC to take certain actions in advance of the sale.
FMC Corp director Eduardo E. Cordeiro acquired 169 shares of common stock on October 15, 2026, issued under dividend equivalent rights in connection with vested restricted stock units. His directly held common-stock position following the award was 41,180 shares. This was a compensation-related acquisition, not a market purchase.